OCEA
Price:
$0.72
Market Cap:
$24.95M
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium f...[Read more]
Industry
Biotechnology
IPO Date
2021-11-08
Stock Exchange
NASDAQ
Ticker
OCEA
According to Ocean Biomedical, Inc.’s latest financial reports and current stock price. The company's current ROE is 64.85%. This represents a change of -103.20% compared to the average of -2029.57% of the last 4 quarters.
The mean historical ROE of Ocean Biomedical, Inc. over the last ten years is 281.01%. The current 64.85% ROE has changed -76.92% with respect to the historical average. Over the past ten years (40 quarters), OCEA's ROE was at its highest in in the March 2021 quarter at 2.10%. The ROE was at its lowest in in the June 2021 quarter at -21438.32%.
Average
281.01%
Median
93.85%
Minimum
0.54%
Maximum
935.82%
Discovering the peaks and valleys of Ocean Biomedical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 967.16%
Maximum Annual ROE = 935.82%
Minimum Annual Increase = -99.94%
Minimum Annual ROE = 0.54%
Year | ROE | Change |
---|---|---|
2022 | 0.54% | -99.94% |
2021 | 935.82% | 967.16% |
2020 | 87.69% | -12.31% |
The current ROE of Ocean Biomedical, Inc. (OCEA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
341.35%
5-year avg
281.01%
10-year avg
281.01%
Ocean Biomedical, Inc.’s ROE is greater than Enveric Biosciences, Inc. (-201.01%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), greater than Elevation Oncology, Inc. (-59.73%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-58.44%), greater than Zura Bio Limited (-39.61%), less than eFFECTOR Therapeutics, Inc. (2.18%),
Company | ROE | Market cap |
---|---|---|
-201.01% | $3.31M | |
-505.74% | $4.62M | |
-59.73% | $35.67M | |
29.68% | $5.24M | |
-58.44% | $1.45M | |
-39.61% | $178.25M | |
2.18% | $941.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocean Biomedical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ocean Biomedical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ocean Biomedical, Inc.'s ROE?
How is the ROE calculated for Ocean Biomedical, Inc. (OCEA)?
What is the highest ROE for Ocean Biomedical, Inc. (OCEA)?
What is the 3-year average ROE for Ocean Biomedical, Inc. (OCEA)?
What is the 5-year average ROE for Ocean Biomedical, Inc. (OCEA)?
How does the current ROE for Ocean Biomedical, Inc. (OCEA) compare to its historical average?